James Armitage

James Armitage

Director/Board Member en TESARO INC .

Fortuna: 146 797 $ al 31/03/2024

77 años
Health Technology
Consumer Services
Health Services

Perfil

James O.
Armitage
is currently the Director at Tesaro, Inc., the Independent Director at Cardiff Oncology, Inc., and a Professor-Internal Medicine at the University of Nebraska Medical Center.
Previously, he served as the Director at MGI PHARMA, Inc. from 2006 to 2008.
He also held positions as the President & Director of the American Society of Clinical Oncology, Inc. and as the President of the American Society for Blood & Marrow Transplantation.
Dr. Armitage obtained his undergraduate degree from the University of Nebraska and his doctorate from the University of Nebraska Medical Center.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/06/2023 27 490 ( 0.06% ) 146 797 $ 31/03/2024

Cargos activos de James Armitage

EmpresasCargoInicio
TESARO INC Director/Board Member 09/05/2013
CARDIFF ONCOLOGY, INC. Director/Board Member 22/04/2020
University of Nebraska Medical Center Corporate Officer/Principal 01/01/1982
Todos los cargos activos de James Armitage

Antiguos cargos conocidos de James Armitage.

EmpresasCargoFin
Director/Board Member 29/01/2008
American Society for Blood & Marrow Transplantation President -
President -
Ver el detalle de la experiencia de James Armitage.

Formación de James Armitage.

University of Nebraska Undergraduate Degree
University of Nebraska Medical Center Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de James Armitage.

Relaciones

96

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
CARDIFF ONCOLOGY, INC.

Health Technology

Empresas privadas4

Health Technology

Health Technology

Health Services

American Society for Blood & Marrow Transplantation

Ver las conexiones de la empresa